iNOPulse for COVID-19

NCT04398290 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IRB AND FDA REVIEWS DEFERRED

Conditions

COVID-19
Hypoxemia
Hypoxemic Respiratory Failure

Interventions

DRUG: Inhaled nitric oxide (iNO)
DRUG: Nitrogen gas
DRUG: Oxygen gas

Sponsor

Roger Alvarez

Collaborators

[object Object]